1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Insulin, Glucose, and the Metabolic Syndrome in Cardiovascular Behavioral Medicine
2022) p.809-831(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Genetic risk of type 2 diabetes modifies the effects of a lifestyle intervention aimed at the prevention of gestational and postpartum diabetes
(
- Contribution to journal › Article
- 2019
-
Mark
The associations of daylight and melatonin receptor 1B gene rs10830963 variant with glycemic traits : the prospective PPP-Botnia study
(
- Contribution to journal › Article
-
Mark
Plasma Heme Scavengers Alpha-1-Microglobulin and Hemopexin as Biomarkers in High-Risk Pregnancies
(
- Contribution to journal › Article
-
Mark
Longitudinal changes in plasma hemopexin and alpha-1-microglobulin concentrations in women with and without clinical risk factors for pre-eclampsia
(
- Contribution to journal › Article
- 2018
-
Mark
Melatonin receptor 1B gene rs10830963 polymorphism, depressive symptoms and glycaemic traits
(
- Contribution to journal › Article
-
Mark
Bivariate genome-wide association study of depressive symptoms with type 2 diabetes and quantitative glycemic traits
(
- Contribution to journal › Article
- 2016
-
Mark
Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes
(
- Contribution to journal › Article
- 2014
-
Mark
Sleep duration and insulin resistance in individuals without type 2 diabetes: The PPP-Botnia Study
(
- Contribution to journal › Article
- 2012
-
Mark
Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: Results from the PPP-Botnia Study
(
- Contribution to journal › Article